摘要 |
Oligomer compositions comprising first and second oligomers are provided wherein at least a portion Of the second oligomer, at least a portion of the first oligomer is complementary to and capble of hybridizing to a selected target nucleic acid, and at least one of the first or second oligomers has a modified base for binding to a cytosine, uracil, or thymine base in the opposite strand. Oligonucleotide&protein compositions are also provided comprising an oligomer complementartary To and capable of hybridizing to a selected target nucleic acid and at least one protein comprising at least a portion of an RNA-induced silencing complex (RISC), wherein the oligomer has a modified base for binding to a cytosine, uracil, or thymine base in the opposite strand. |
申请人 |
ISIS PHARMACEUTICALS, INC.;BAKER, BRENDA, F.;ELDRUP, ANNE, B.;MANOHARAN, MUTHIAH;BHAT, BALKRISHEN;GRIFFEY, RICHARD;SWAYZE, ERIC, E.;CROOKE, STANLEY, T.;RAJEEV, KALLANTHOTTATHIL, G. |
发明人 |
BAKER, BRENDA, F.;ELDRUP, ANNE, B.;MANOHARAN, MUTHIAH;BHAT, BALKRISHEN;GRIFFEY, RICHARD;SWAYZE, ERIC, E.;CROOKE, STANLEY, T.;RAJEEV, KALLANTHOTTATHIL, G. |